North carolina

novo nordisk, semaglutide, fda, form 483, north carolina, quality issues, gmp violations

Novo Nordisk’s semaglutide facility in North Carolina faces FDA scrutiny over quality issues

Anika Sharma

Novo Nordisk’s shares faced a decline following reports that the FDA had raised concerns about manufacturing issues at the company’s ...

Pfizer’s Plant Survives Tornado Damage, Resumes Production

Less than anticipated supply impact from Pfizer’s tornado-damaged factory

SG Tylor

The FDA has addressed the impact of the recent devastating tornado that hit Pfizer’s Rocky Mount facility in North Carolina. ...

Pfizer’s North Carolina Plant Hit by Tornado, Threatening US Drug Supply

Pfizer’s North Carolina Facility Hit by Tornado, Raising Concerns About US Medication Supply

SG Tylor

A massive sterile injectables facility, considered one of the world’s largest, has fallen victim to a devastating natural disaster. On ...